Suppr超能文献

局部晚期累及胸壁的cT3N2(IIIB期)肺癌的胸壁整块切除术:重新审视指南

En bloc chest wall resection in locally advanced cT3N2 (stage IIIB) lung cancer involving the chest wall: Revisiting guidelines.

作者信息

Zywiciel Joseph F, Verm Raymond A, Raad Wissam, Baker Marshall, Freeman Richard, Abdelsattar Zaid M

机构信息

Stritch School of Medicine, Loyola University Chicago, Chicago, Ill.

Department of Thoracic & Cardiovascular Surgery, Loyola University Medical Center, Maywood, Ill.

出版信息

JTCVS Open. 2023 Dec 23;18:221-231. doi: 10.1016/j.xjon.2023.12.007. eCollection 2024 Apr.

Abstract

OBJECTIVES

Current National Comprehensive Cancer Network guidelines recommend definitive chemoradiation rather than surgery for patients with locally advanced clinical stage T3 and N2 (stage IIIB) lung cancer involving the chest wall. The data supporting this recommendation are controversial. We studied whether surgery confers a survival advantage over definitive chemoradiation in the National Cancer Database.

METHODS

We identified all patients with clinical stage T3 and N2 lung cancer in the National Cancer Database from 2004 to 2017 who underwent a lobectomy with en bloc chest wall resection and compared them with patients with clinical stage T3 and N2 lung cancer who had definitive chemoradiation. We used propensity score matching to minimize confounding by indication while excluding patients with tumors in the upper lobes to exclude Pancoast tumors. We used 1:1 propensity score matching and Kaplan-Meir survival analyses to estimate associations.

RESULTS

Of 4467 patients meeting all inclusion/exclusion criteria, 210 (4.49%) had an en bloc chest wall resection. Patients undergoing surgical resection were younger (mean age = 60.3 ± 10.3 years vs 67.5 ± 10.4 years;  < .001) and had more adenocarcinoma (59.0% vs 44.5%;  < .001) but were otherwise similar in terms of sex (37.1% female vs 42.0%;  = .167) and race (Whites 84.3% vs 84.0%;  = .276) compared with the definitive chemoradiation group. After resection, there was an unadjusted 30- and 90-day mortality rate of 3.3% and 9.5%, respectively. A substantial survival benefit with surgical resection persisted after propensity score matching (log-rank  < .001).

CONCLUSIONS

In this large observational study, we found that in select patients, en bloc chest wall resection for locally advanced clinical stage T3 and N2 lung cancer was associated with improved survival compared with definitive chemoradiation. National Comprehensive Cancer Network guidelines should be revisited.

摘要

目的

当前美国国立综合癌症网络(National Comprehensive Cancer Network,NCCN)指南推荐,对于累及胸壁的局部晚期临床分期为T3和N2(IIIB期)肺癌患者,应采用根治性放化疗而非手术治疗。支持这一推荐的数据存在争议。我们在国家癌症数据库中研究了手术治疗相对于根治性放化疗是否具有生存优势。

方法

我们在国家癌症数据库中确定了2004年至2017年间所有临床分期为T3和N2的肺癌患者,这些患者接受了肺叶切除术并整块切除胸壁,并将他们与接受根治性放化疗的临床分期为T3和N2的肺癌患者进行比较。我们使用倾向评分匹配来尽量减少指征性混杂因素,同时排除上叶肿瘤患者以排除潘科斯特肿瘤(Pancoast tumor)。我们使用1:1倾向评分匹配和Kaplan-Meir生存分析来评估相关性。

结果

在4467例符合所有纳入/排除标准的患者中,210例(4.49%)进行了整块胸壁切除术。接受手术切除的患者更年轻(平均年龄=60.3±10.3岁 vs 67.5±10.4岁;P<0.001),腺癌更多(59.0% vs 44.5%;P<0.001),但在性别(女性37.1% vs 42.0%;P=0.167)和种族(白人84.3% vs 84.0%;P=0.276)方面与根治性放化疗组相似。切除术后,未调整的30天和90天死亡率分别为3.3%和9.5%。倾向评分匹配后,手术切除仍具有显著的生存获益(对数秩检验P<0.001)。

结论

在这项大型观察性研究中,我们发现,对于部分患者,局部晚期临床分期为T3和N2的肺癌进行整块胸壁切除术与根治性放化疗相比,生存情况有所改善。应重新审视NCCN指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6474/11056476/c3bd1d13686f/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验